Skip to main content

Reha Technology AG has terminated the strategic
partnership with Hocoma retroactively as of February 17, 2023 with immediate effect.

Olten, Switzerland – Reha Technology AG announces that its strategic partnership with Hocoma has been terminated as of February 17th, 2023. Reha Technology will continue to advance its leading end-effector gait therapy with the G-EO gait trainer and make it available to the market worldwide. 

Reha Technology regrets that the partnership could not be continued. The company has decided to terminate the partnership because Hocoma did not comply with its contractual agreements to actively distribute and expand the customer base as agreed. Despite repeated efforts to maintain the partnership, the decision was ultimately made to end the collaboration. 

Reha Technology AG will expand its presence as a reliable distributor and service partner in providing the G-EO gait trainer with its unique end-effector gait therapy to the market in a new and strengthened way. 

In countless studies, the G-EO has demonstrated clinical evidence in end-effector-based gait therapy compared to conventional therapy. The gait robot uniquely supports functional clinical outcomes in adult and pediatric patients with neurological impairments resulting from stroke, traumatic brain injury, spinal cord injury, infantile cerebral palsy (ICP), Parkinson’s disease, and other neurologically-induced movement disorders. The use of gait trainers in clinics and practices significantly increases the cost-effectiveness and efficiency of gait rehabilitation, relieves therapists of physical work, and leads patients to more effective and targeted self-reliant walking. 

Reha’s robotic-assisted therapy devices maximize functional clinical outcomes for adult and pediatric patients with neurological impairments resulting from stroke, traumatic brain and spinal cord injuries, infantile cerebral palsy, Parkinson’s, as well as other neurologic conditions. Reha’s ambition is to improve the quality of life for those who have been injured or disabled by illness or accident. 

“We regret that we can no longer continue this strategic partnership, but we are determined to further expand our leading position in end-effector gait therapy with the G-EO,” said Peter Pauli, Chairman of Reha Technology AG. “We believe that end-effector-based gait therapy will have a sustainable, positive impact on patient rehabilitation and quality of life, and we look forward to offering the market an excellent gait robot with the G-EO.” 

Press Release, 738KB (PDF)

The Johanniter-Ordenshäuser rehabilitation center in Bad Oeynhausen is using Reha Technology’s G-EO gait trainer for cutting-edge treatment

Team of therapists at Johanniter-Ordenshäuser

In future, neurology patients at the Johanniter-Ordenshäuser rehabilitation center in Bad Oeynhausen will be treated with a cutting edge robot-assisted gait therapy system. The G-EO, model L, which is part of Reha Technology’s G-EO systems family, will enable the center’s highly qualified therapists to provide patients with treatment which is even more specific, effective and tailored to their individual patient’s requirements and abilities. This will improve the quality and cost-effectiveness of the treatment available at the center. 

Reha Technology AG is a pioneer in the field of robot-assisted gait therapy used for neurorehabilitation. For years, the company has based its technology around the electromechanical end-effector principle. Reha Technology can look back on over 10 successful years of developing and perfecting all the key elements required for high performance, high quality and sustainable therapy with the G-EO system family.

G-EO, model „L“

The G-EOL model – the „L“ stands for Level Walking – can be used to provide performance-based therapy at a very early stage for a wide range of neurological pathologies. The modular nature of the system helps therapists to tailor objectives and the entire therapy process to individual patients. It also means that the system can be used to treat a wide range of patients. The intensity and repetitive nature of robot-assisted gait training leads to positive neuroplastic changes in the central nervous system of patients. The ability to reproduce high-quality and high-intensity therapy at short intervals represents a significant upgrade for both therapists and patients. The G-EO has clearly improved the cost-effectiveness of a wide range of treatment plans by making them more effective and providing time savings. “We are very proud that our neurology patients will have access to therapy using one of the most advanced robot-assisted gait trainers available. The ability to reproduce high-quality and high-intensity therapy with the G-EO gait robot represents a significant and sustainable upgrade for both therapists and patients” emphasized Michael Schelp, Commercial Manager for Johanniter-Ordenshäuser Bad Oeynhausen. 

The intensity and repetitive nature of robot-assisted gait training leads to positive neuroplastic changes in the central nervous system of patients, while also improving their strength and endurance. The high quality and performance-based therapy provided for neurology patients at the Johanniter Ordenshäusern will be enhanced by the unique ability to make ongoing changes to important parameters like cadence, step length, step height and ankle angle without interrupting therapy. The body weight system can also be set to be dynamic or static during gait therapy. The G-EO, model L“, includes a feature which makes it possible to adjust the hip guide on three planes using a back cushion with a cable guide – frontal (belly/back, electrical), sagittal (left/right, mechanical) and transverse (top/bottom, electrical) – to optimize hip and body positioning.The Johanniter Ordenshäuser rehabilitation center will use the advanced G-EO robot-assisted gait trainer from Reha Technology to provide the best possible day-to-day gait therapy for neurology patients, with a focus on cutting-edge technology, cost-effectiveness and efficiency.

The intensity and repetitive nature of robot-assisted gait training leads to positive neuroplastic changes in the central nervous system of patients, while also improving their strength and endurance. The high quality and performance-based therapy provided for neurology patients at the Johanniter-Ordenshäuser will be enhanced by the unique ability to make ongoing changes to important parameters like cadence, step length, step height and ankle angle without interrupting therapy. The body weight system can also be set to be dynamic or static during gait therapy. The G-EOL includes a feature which makes it possible to adjust and guide the hips in three planes (anterior, posterior, laterally) using a back cushion with a cable guides to optimize hip and body positioning during walking.

The Johanniter-Ordenshäuser rehabilitation center will use the advanced G-EOL robot-assisted gait trainer from Reha Technology to provide the best possible day-to-day gait therapy for neurology patients, with a focus on cutting-edge technology, cost-effectiveness and efficiency.

Press release (pdf)

Reha Technology launches the latest generation of its «G-EOS » robot-assisted gait trainer

The market introduction of the simplified construction and functionally improved base model, the «G-EOL», in October 2018 is now followed by the launch of the «G-EOS», the latest generation from the successful and unique
Reha Technology system line of robot-assisted gait trainers employing the end-effector principle. The «G-EOS» is the top model in the system line and stands out for its unrivaled diversity of 6 gait training trajectories geared to
the needs of everyday life, such as forwards and backwards walking on level ground, walking on slopes, climbing and descending stairs, as well as 3 activity modes for patient support: passive, active-assistive and active.

Interested in learning more about the world of G-EO?